Overview

CSL311 and Cell Viability in Asthma

Status:
Completed
Trial end date:
0000-00-00
Target enrollment:
Participant gender:
Summary
To examine the effect of blocking signaling through the β-chain on viability, activation and differentiation of eosinophils and their progenitors collected from sputum, blood and bone marrow samples collected pre and post-allergen challenge from mild atopic asthmatic subjects.
Phase:
Phase 2
Details
Lead Sponsor:
Hamilton Health Sciences Corporation
Collaborator:
CSL Limited